Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Bingol, T. Cagatay, L. Pur, B. Kiran, Z. Gulbaran, P. Cagatay, F. Erkan (Istanbul, Turkey). Can plasma arginase levels differantiate asthma and COPD?. Eur Respir J 2007; 30: Suppl. 51, 2226

Member's Comments

No comment yet.

Related content which might interest you: Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1515-1516 Year: 2015 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1514-1515 Year: 2015 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Changes of urotensin II in induced sputum and plasma of patients with COPD and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 672s Year: 2006 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 The study of bronchospastic eicosanoids levels in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Plasma eotaxin level in children with acute bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003 Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002 Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma Source: Eur Respir J 2005; 26: Suppl. 49, 584s Year: 2005 Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Comparable serum periostin levels among a Japanese population with asthma, COPD, and asthma-COPD overlap Source: International Congress 2017 – Many faces of asthma assessment Year: 2017 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis Source: Eur Respir J 2015; 46: 1501-1503 Year: 2015